GRWD1 affects the proliferation, apoptosis, invasion and migration of triple negative breast cancer through the Notch signaling pathway-Reference-Cited by-同舟云学术

GRWD1 affects the proliferation, apoptosis, invasion and migration of triple negative breast cancer through the Notch signaling pathway

Published:2022-05-30 Issue:1 Volume:24 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Yao Liang¹,Tian Fuguo¹

Affiliation:

1. Department of Breast Surgery, Shanxi Provincial Tumor Hospital and Affiliated Tumor Hospital of Shanxi Medical University, Taiyuan, Shanxi 030013, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Reference43 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA cancer J Clin,2021

2. Triple-negative breast cancer: Current practice and future directions;Costa;J Oncol Pract,2017

3. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California cancer registry;Bauer;Cancer,2007

4. Atypical distant metastasis of breast malignant phyllodes tumors: A case report and literature review;de Foucher;Case Rep Obstet Gynecol,2017

5. Surgical management of breast cancer in africa: A continent-wide review of intervention practices, barriers to care, and adjuvant therapy;Sutter;J Glob Oncol,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative Breast Cancer by Activating Notch Signaling;Revista de investigaci�n Cl�nica;2024-02-26

2. COMBINE: A Comprehensive Multi-Omics Approach for Improving Breast Cancer Prognosis Classification in African American Women;2024-01-23

3. GRWD1 Over-Expression Promotes Gastric Cancer Progression by Activating Notch Signaling Pathway via Up-Regulation of ADAM17;Digestive Diseases and Sciences;2024-01-03

4. The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer;Cancers;2023-08-03

5. The efficacy of CB-103, a first-in-class transcriptional Notch inhibitor, in preclinical models of breast cancer;2023-07-07